US Patent 11964168 Diffusing alpha-emitter radiation therapy for prostate cancer
Patent 11964168 was granted and assigned to Alpha Tau Medical on April, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 24 Apr, 2024
Golden AI
Edits made to:
Infobox (+31 properties)
Article (+473 characters)
US Patent 11964168 Diffusing alpha-emitter radiation therapy for prostate cancer
Article
Patent abstract
A method for treating a tumor, comprising identifying a tumor as a prostate cancer tumor and implanting in the tumor identified as a prostate cancer tumor, at least one diffusing alpha-emitter radiation therapy (DaRT) source with a suitable radon release rate and for a given duration, such that the source provides during the given duration a cumulated activity of released radon between 7 Mega becquerel (MBq) hour and 14.7 MBq hour, per centimeter length.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Amnon Gat0
Guy Heger0
Ishai Luz0
Itzhak Kelson0
Lior Arazi0
Maayan Hedva Vatarescu0
Mirta Duman{hacek over (c)}ić0
Ofer Magen0
Robert Den0
Tomer Cooks0
Vered Domankevich0
Yona Keisari0
Date of Patent
April 23, 2024
0Patent Application Number
180944290
Date Filed
January 9, 2023
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11964168 Diffusing alpha-emitter radiation therapy for prostate cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
